JP2001511155A5 - - Google Patents

Download PDF

Info

Publication number
JP2001511155A5
JP2001511155A5 JP1998533248A JP53324898A JP2001511155A5 JP 2001511155 A5 JP2001511155 A5 JP 2001511155A5 JP 1998533248 A JP1998533248 A JP 1998533248A JP 53324898 A JP53324898 A JP 53324898A JP 2001511155 A5 JP2001511155 A5 JP 2001511155A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998533248A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001511155A (ja
JP4397973B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/002289 external-priority patent/WO1998033497A1/en
Publication of JP2001511155A publication Critical patent/JP2001511155A/ja
Publication of JP2001511155A5 publication Critical patent/JP2001511155A5/ja
Application granted granted Critical
Publication of JP4397973B2 publication Critical patent/JP4397973B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP53324898A 1997-02-04 1998-02-03 瞼の毛髪の成長を刺激するための局所的組成物 Expired - Lifetime JP4397973B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3723797P 1997-02-04 1997-02-04
US60/037,237 1997-02-04
PCT/US1998/002289 WO1998033497A1 (en) 1997-02-04 1998-02-03 Method of enhancing hair growth

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008307929A Division JP2009102336A (ja) 1997-02-04 2008-12-02 毛髪の成長の増強方法

Publications (3)

Publication Number Publication Date
JP2001511155A JP2001511155A (ja) 2001-08-07
JP2001511155A5 true JP2001511155A5 (enExample) 2005-10-06
JP4397973B2 JP4397973B2 (ja) 2010-01-13

Family

ID=21893222

Family Applications (2)

Application Number Title Priority Date Filing Date
JP53324898A Expired - Lifetime JP4397973B2 (ja) 1997-02-04 1998-02-03 瞼の毛髪の成長を刺激するための局所的組成物
JP2008307929A Withdrawn JP2009102336A (ja) 1997-02-04 2008-12-02 毛髪の成長の増強方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008307929A Withdrawn JP2009102336A (ja) 1997-02-04 2008-12-02 毛髪の成長の増強方法

Country Status (8)

Country Link
US (1) US6262105B1 (enExample)
EP (1) EP1021179B1 (enExample)
JP (2) JP4397973B2 (enExample)
AT (1) ATE266397T1 (enExample)
AU (1) AU750039B2 (enExample)
CA (1) CA2279967C (enExample)
DE (1) DE69823852T2 (enExample)
WO (1) WO1998033497A1 (enExample)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69823852T2 (de) 1997-02-04 2005-05-19 Johnstone, Murray A., Seattle Verfahren zur förderung des haarwuchses und entwicklung des haarsystems
NZ513825A (en) 1999-03-05 2001-09-28 Procter & Gamble C 16 unsaturated FP-selective prostaglandins analogs
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
JP4162823B2 (ja) * 2000-01-07 2008-10-08 花王株式会社 頭髪用化粧料
US6579542B1 (en) * 2000-03-02 2003-06-17 Cecil Faulkner Treating feline-specific disorders by orally administering Hydrastis canadensis
US20020013294A1 (en) * 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US20020037914A1 (en) * 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) * 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
FR2812192B1 (fr) * 2000-07-28 2003-01-31 Oreal Utilisation d'antagonistes de recepteur des prostaglandines ep-3 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
FR2812190B1 (fr) * 2000-07-28 2003-01-31 Oreal Utilisation d'agonistes non prostanoiques des recepteurs des prostaglandines ep-2 et/ou ep-4 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
FR2812191B1 (fr) * 2000-07-28 2003-10-17 Oreal Utilisation d'agonistes du recepteur des prostaglandines e2 (ep-3) pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques
FR2812193B1 (fr) * 2000-07-28 2003-10-24 Oreal Utilisation d'antagoniste des recepteurs des prostaglandines ep-2 et/ou ep-4 pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques
CA2449462A1 (en) * 2001-07-25 2003-02-06 Alcon, Inc. Methods for promotion of hair growth comprising topical application of prostaglandin analogues
US9216183B2 (en) 2002-02-04 2015-12-22 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
AU2012261499B2 (en) * 2002-02-04 2016-05-12 Allergan, Inc. Method of enhancing hair growth
US8758733B2 (en) 2002-02-04 2014-06-24 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US7351404B2 (en) 2002-02-04 2008-04-01 Allergan, Inc. Method of enhancing hair growth
US7320967B2 (en) * 2002-04-23 2008-01-22 L'oreal Cosmetic composition, method of cosmetic treatment and preparation of a composition for promoting the growth and/or preventing or delaying the loss of hair
WO2003090699A1 (fr) * 2002-04-23 2003-11-06 L'oreal Composition cosmetique pour favoriser la pousse et/ou empecher ou retarder la chute des cheveux
US20030199590A1 (en) * 2002-07-25 2003-10-23 Cagle Gerald D Prostaglandin analogues for promotion of hair growth
US20040115234A1 (en) * 2002-09-24 2004-06-17 Gewirtz Joan T. Cosmetic composition
US7326717B2 (en) 2003-05-06 2008-02-05 L'oreal Pyrimidine n-oxide compounds for stimulating the growth of keratin fibers and/or reducing loss thereof
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
US20050058614A1 (en) * 2003-09-15 2005-03-17 Allergan, Inc. Methods for the treatment of gray hair using cyclopentane(ene) heptan(en)oic acid amides
EP1830793A1 (en) * 2004-12-29 2007-09-12 R-Tech Ueno, Ltd. Composition and method for scalp and hair treatment
CN101160114B (zh) * 2004-12-29 2013-02-06 株式会社·R-技术上野 头皮和毛发处理组合物及方法
US20060177403A1 (en) * 2005-02-08 2006-08-10 L'oreal Cosmetic/dermatological compositions comprising a derivative of glucose and of vitamin F and A specific surfactant
US20070009468A1 (en) * 2005-05-12 2007-01-11 Bernstein Eric F Photodynamic method of inducing the growth of hair
JP5780690B2 (ja) * 2005-08-25 2015-09-16 大正製薬株式会社 発毛剤組成物
WO2007111806A2 (en) 2006-03-23 2007-10-04 Massachusetts Eye And Ear Infirmary Cyclopentane heptanoic acid compounds for reducing body fat
US7879910B1 (en) 2006-10-10 2011-02-01 Jan Marini Skin Research, Inc. Compositions and methods for promoting lush hair growth
FR2916350B1 (fr) * 2007-05-22 2009-07-24 Oreal Utilisation d'agonistes du recepteur du thromboxame pour moduler la croissance pilaire
US20090018204A1 (en) * 2007-07-13 2009-01-15 Brinkenhoff Michael C Composition and method for enhancing hair growth
FR2920309B1 (fr) 2007-08-28 2010-05-28 Galderma Res & Dev Utilisation de travoprost pour traiter la chute des cheveux
US20100074857A1 (en) * 2008-09-23 2010-03-25 Pamela Lipkin Compositions and methods to treat epithelial-related conditions
JP2011502152A (ja) * 2007-10-31 2011-01-20 パメラ リプキン プロスタグランジン類似体組成物及び上皮関連症状の治療方法
US8455547B2 (en) * 2008-02-05 2013-06-04 Allergan, Inc. Substituted cyclopentanes having prostaglandin activity
US7964596B2 (en) * 2008-03-07 2011-06-21 Allergan, Inc. Therapeutic compounds
CA2724340A1 (en) 2008-05-14 2009-11-19 Peter Thomas Roth Labs, Llc Prostaglandin based compositions and method of use thereof
US20080275118A1 (en) * 2008-06-12 2008-11-06 Shaw Mari M Health and cosmetic composition and regime for stimulating hair growth and thickening on the head, including the scalp, eyelashes, and eyebrows, and which discourages hair loss
JP5645381B2 (ja) * 2008-09-04 2014-12-24 参天製薬株式会社 15,15−ジフルオロプロスタグランジンF2α誘導体を有効成分として含有する毛髪成長促進剤
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) * 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US20100204335A1 (en) * 2008-12-01 2010-08-12 Allergan, Inc. Kit and composition for eyelash growth
WO2010064203A1 (en) 2008-12-02 2010-06-10 L'oreal Combination of reduced glutathione and amino acids for improving the quality of the hair in women
FR2941150B1 (fr) * 2009-01-16 2013-01-11 Oreal Produit pour la prevention ou le traitement du blanchissement des cheveux.
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
US20100305047A1 (en) * 2009-05-27 2010-12-02 Allergan, Inc. Cyclosporin derivatives for enhancing the growth of hair
FR2949052B1 (fr) 2009-08-13 2015-03-27 Oreal Procede de traitement cosmetique du cuir chevelu.
EP2498784A2 (en) 2009-11-09 2012-09-19 Allergan, Inc. Compositions for enhancing hair growth
NZ628266A (en) 2009-11-09 2016-02-26 Allergan Inc Compositions and methods for stimulating hair growth
US9149484B2 (en) 2009-11-09 2015-10-06 Allergan, Inc. Compositions and methods for stimulating hair growth
BR112013002584A2 (pt) 2010-08-02 2016-06-07 Pharma Patent Holding Inc composição, processo de kit para aperfeiçoamento de cabelo
CA2819859A1 (en) 2010-12-06 2012-06-14 Follica, Inc. Methods for treating baldness and promoting hair growth
ES2687494T3 (es) 2011-01-19 2018-10-25 Topokine Therapeutics, Inc. Métodos y composiciones para reducir la grasa corporal
US8859616B2 (en) 2011-01-21 2014-10-14 Allergan, Inc. Compounds and methods for enhancing hair growth
KR101623132B1 (ko) 2011-06-08 2016-05-20 에스케이케미칼주식회사 속눈썹 성장용 조성물
US8426471B1 (en) 2011-12-19 2013-04-23 Topokine Therapeutics, Inc. Methods and compositions for reducing body fat and adipocytes
WO2016144958A1 (en) 2015-03-08 2016-09-15 Case Western Reserve University Inhibitors of short-chain dehydrogenase activity for treating fibrosis
EP3295940A1 (en) 2012-04-16 2018-03-21 Case Western Reserve University Compositions and methods of modulating 15-pgdh activity
WO2013180229A1 (ja) 2012-05-30 2013-12-05 旭硝子株式会社 育毛用組成物
US9987213B2 (en) 2012-06-13 2018-06-05 Edward Dunne Corboy, JR. Topical dihydrotestosterone (DHT) for promoting hair growth—containing formulations
CA2869676C (en) 2012-11-21 2015-06-23 Topokine Therapeutics, Inc. Uses and compositions comprising a thiazolidinedione and oleic acid for locally increasing subcutaneous fat
NO2753788T3 (enExample) 2013-05-10 2018-06-16
WO2014186504A1 (en) 2013-05-15 2014-11-20 Topokine Therapeutics, Inc. Methods and compositions for topical delivery of prostaglandins to subcutaneous fat
CA2927730A1 (en) 2013-10-15 2015-05-07 Case Western Reserve University Compositions and methods of modulating short-chain dehydrogenase activity
US10188661B2 (en) 2014-06-27 2019-01-29 Topokine Therapeutics, Inc. Topical dosage regimen
CN111743882A (zh) 2015-09-30 2020-10-09 诺瓦利克有限责任公司 半氟化化合物和其组合物
JP7595413B2 (ja) 2016-11-30 2024-12-06 ケース ウエスタン リザーブ ユニバーシティ 15-pgdh阻害剤とコルチコステロイドおよび/またはtnf阻害剤との組み合わせならびにその使用
WO2018145080A1 (en) 2017-02-06 2018-08-09 Case Western Reserve University Compositions and methods of modulating short-chain dehydrogenase activity
CN110891568A (zh) 2017-04-07 2020-03-17 凯斯西储大学 用于治疗冠状动脉病症的短链脱氢酶活性的抑制剂
MX388460B (es) 2017-04-21 2025-03-20 Dermaliq Therapeutics Inc Composiciones de yodo.
CN112153970A (zh) 2018-04-27 2020-12-29 诺瓦利克有限责任公司 用于治疗青光眼的包含他氟前列素的眼用组合物
SG11202102820VA (en) 2018-10-12 2021-04-29 Novaliq Gmbh Ophthalmic composition for treatment of dry eye disease
PE20212246A1 (es) 2018-11-21 2021-11-24 Univ Case Western Reserve Composiciones y metodos para modular la actividad de deshidrogenasas de cadena corta
FR3089413B1 (fr) 2018-12-06 2021-02-19 Fabre Pierre Dermo Cosmetique Extrait de Garcinia mangostana pour promouvoir la croissance capillaire
EA202290013A1 (ru) 2019-06-28 2022-03-18 Общество С Ограниченной Ответственностью "Регеус" Средство для усиления роста волос
FR3099699B1 (fr) 2019-08-06 2025-09-26 Fabre Pierre Dermo Cosmetique Extrait d’akènes de Silybum marianum (L.) Gaertn. pour promouvoir la croissance capillaire
CA3140841C (en) * 2019-08-07 2025-05-06 Aneira Pharma, Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF HAIR LOSS
CN114206344A (zh) * 2019-08-09 2022-03-18 诺瓦利克有限责任公司 包含前列腺素类似物的局部组合物
EP3895685A1 (en) 2020-04-14 2021-10-20 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Natural composition for hair growth stimulation and hair loss prevention and treatment without preservatives
EP3895686B1 (en) 2020-04-14 2025-04-09 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Natural composition for hair growth stimulation and hair loss prevention and treatment
TW202208376A (zh) 2020-05-20 2022-03-01 美國凱斯西方瑞瑟夫大學 調節短鏈脫氫酶活性之組成物及方法
JP7141025B1 (ja) * 2021-11-11 2022-09-22 エルデシエロ プライベート リミテッド 化合物、組成物、方法、及び製造方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139619A (en) 1976-05-24 1979-02-13 The Upjohn Company 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth
US4311707A (en) 1979-02-12 1982-01-19 American Cyanamid Company Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions
US4599353A (en) 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
ES8607921A1 (es) 1984-07-31 1986-06-16 Syntex Inc Procedimiento para preparar derivados de acidos 11-sustitui-dos-16-fenoxi y 16-fenoxi sustituido-prostatrienoicos
JPS61218510A (ja) * 1985-03-22 1986-09-29 Dai Ichi Seiyaku Co Ltd 毛髪用剤
US4883819A (en) 1986-07-31 1989-11-28 The Trustees Of Columbia University In The City Of New York Use of A, B and C prostaglandins and derivatives thereof to treat ocular hypertension and glaucoma
US4824857A (en) 1986-05-16 1989-04-25 Yasumasa Goh Use of prostaglandin D2 -active substances
US4952581A (en) 1987-04-03 1990-08-28 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
DE3876050T2 (de) 1987-09-18 1993-03-25 Ueno Seiyaku Oyo Kenkyujo Kk Okulare hypotensivagenzien.
SE8703854D0 (sv) 1987-10-07 1987-10-07 Pharmacia Ab Prostaglandinderivat for behandling av glaukom eller okuler hypertension
ES2213504T1 (es) 1988-09-06 2004-09-01 Pfizer Health Ab Derivados de prostaglandina para el tratamiento del glaucoma o hipertension ocular.
US5321128A (en) 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US4968812A (en) 1989-06-23 1990-11-06 Shell Oil Company Spirolactonelactams
JPH0737390B2 (ja) * 1989-08-29 1995-04-26 久光製薬株式会社 軟膏組成物
JPH0737389B2 (ja) * 1989-08-29 1995-04-26 久光製薬株式会社 プロスタグランジンe1含有の軟膏剤
US5288754A (en) 1992-02-04 1994-02-22 Allergan, Inc. Polar C-1 esters of prostaglandins
JP3102141B2 (ja) * 1992-05-29 2000-10-23 東レ株式会社 養毛育毛剤
US5352708A (en) 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US6248751B1 (en) * 1993-05-28 2001-06-19 Gurpreet S. Ahluwalia Inhibition of hair growth
FR2711060B1 (fr) * 1993-10-13 1995-11-17 Oreal Procédé pour modifier la pousse des poils et/ou des cheveux et compositions utilisables à cet effet.
SE9303444D0 (sv) * 1993-10-20 1993-10-20 Kabi Pharmacia Ab New use of prostaglandins
DE69823852T2 (de) 1997-02-04 2005-05-19 Johnstone, Murray A., Seattle Verfahren zur förderung des haarwuchses und entwicklung des haarsystems

Similar Documents

Publication Publication Date Title
JP2000509912A5 (enExample)
JP2000509942A5 (enExample)
JP2000509637A5 (enExample)
JP2000510751A5 (enExample)
JP2000509635A5 (enExample)
JP2002512549A5 (enExample)
JP2001523092A5 (enExample)
JP2001511155A5 (enExample)
JP2001517164A5 (enExample)
JP2000509587A5 (enExample)
JP2000508866A5 (enExample)
JP2000510793A5 (enExample)
JP2001508909A5 (enExample)
JP2001500245A5 (enExample)
JP2001511644A5 (enExample)
JP2002504174A5 (enExample)
JP2002514367A5 (enExample)
JP2000509804A5 (enExample)
JP2000509853A5 (enExample)
JP2001512456A5 (enExample)
JP2000509755A5 (enExample)
JP2000510969A5 (enExample)
JP2000510247A5 (enExample)
JP2002507956A5 (enExample)
JP2000509520A5 (enExample)